Madoka Mori-Yoshimura Selected Research

N,N-diacetylchitobiose

2/2017

Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Madoka Mori-Yoshimura Research Topics

Disease

12	Muscular Diseases (Myopathy) 01/2022 - 07/2012
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2022 - 12/2013
4	Inclusion Body Myositis 01/2021 - 01/2019
4	Muscular Dystrophies (Muscular Dystrophy) 10/2017 - 09/2010
3	Respiratory Insufficiency (Respiratory Failure) 11/2017 - 03/2012
2	Muscle Weakness 01/2022 - 05/2019
2	Aspiration Pneumonia 01/2021 - 01/2020
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2020 - 01/2020
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2017 - 01/2017
2	Nonaka type Distal myopathy 09/2015 - 07/2012
1	Neuronal intranuclear inclusion disease 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2022
1	Diabetes Mellitus 01/2021
1	MELAS Syndrome (Syndrome, MELAS) 01/2021
1	Diarrhea 01/2021
1	Exanthema (Rash) 01/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Glucose Intolerance 01/2021
1	Rhabdomyosarcoma 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Airway Obstruction (Choking) 01/2019
1	Myocardial Infarction 01/2019
1	Adenocarcinoma of Lung 01/2019
1	Spasm (Spasms) 01/2019
1	Hemorrhage 01/2019
1	Atrophy 11/2017
1	Atrioventricular Block 10/2017
1	Distal Myopathies (Distal Muscular Dystrophy) 02/2017
1	Facioscapulohumeral Muscular Dystrophy 06/2016
1	Camptocormia 01/2016
1	Frontotemporal Dementia (Semantic Dementia) 01/2016
1	Osteitis Deformans (Paget's Disease of Bone) 01/2016
1	Nemaline Myopathies (Nemaline Myopathy) 01/2016
1	Monoclonal Gammopathy of Undetermined Significance 01/2016
1	Heart Failure 10/2015
1	Renal Insufficiency (Renal Failure) 10/2015
1	Muscular Atrophy (Muscle Atrophy) 09/2015
1	Neurodegeneration with brain iron accumulation (NBIA) 05/2015
1	Hereditary Myopathy with Early Respiratory Failure 05/2015
1	Intellectual Disability (Idiocy) 05/2015

Drug/Important Bio-Agent (IBA)

4	Racemases and Epimerases (Epimerases and Racemases)IBA 02/2017 - 07/2012
4	Uridine Diphosphate (UDP)IBA 02/2017 - 07/2012
4	N-acylmannosamine kinaseIBA 10/2014 - 07/2012
3	DystrophinIBA 03/2022 - 10/2020
3	bimagrumabIBA 01/2021 - 01/2019
3	Glucosamine (Dona)IBA 10/2014 - 07/2012
2	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2017
2	UDP acetylglucosamine-2-epimeraseIBA 01/2022 - 07/2012
2	Oxidoreductases (Dehydrogenase)IBA 10/2017 - 01/2017
2	EnzymesIBA 02/2017 - 09/2010
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 02/2017 - 09/2015
2	Phosphotransferases (Kinase)IBA 02/2017 - 11/2012
2	AntibodiesIBA 01/2017 - 06/2016
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	MorpholinosIBA 01/2021
1	eteplirsenIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	OligonucleotidesIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021
1	SteroidsIBA 03/2020
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 03/2020
1	Riluzole FDA LinkGeneric 03/2020
1	Activins (Activin)IBA 12/2019
1	Ephedrine FDA LinkGeneric 05/2019
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	PlasticsIBA 01/2019
1	N,N-diacetylchitobioseIBA 02/2017
1	5' Untranslated Regions (5' UTR)IBA 02/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Signal Recognition ParticleIBA 06/2016
1	Anti-Idiotypic AntibodiesIBA 06/2016
1	Valosin Containing ProteinIBA 01/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2016
1	Poly(A)-Binding Protein IIIBA 01/2016
1	Methylprednisolone FDA LinkGeneric 01/2016
1	DiureticsIBA 10/2015
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	IronIBA 05/2015

Therapy/Procedure

6	Therapeutics 03/2020 - 12/2013
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2017 - 01/2013
2	Immunotherapy 10/2017 - 01/2016
1	Continuous Positive Airway Pressure 01/2022
1	Myotomy 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Respiratory Therapy (Therapy, Respiratory) 01/2020
1	Intravenous Administration 12/2019
1	Canes (Cane) 01/2019
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016
1	Plasmapheresis 01/2016